Jason B. Daly, EVP and Chief Legal Officer at Amneal Pharmaceuticals ($AMRX), made one open market sale of company shares in the last year, totaling $199,100. His most recent transaction occurred on August 12, 2025. Among 11,678 insiders tracked for sales, Daly ranks 8,432nd by value, well below the average of $8.6 million per seller across 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 24258 | $0.00 | 72,774.0000 | 324,754,000 | 25.00% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 22645 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 15580 | $13.30 | 251,784.0000 | 324,754,000 | 5.83% | 0.00% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 35880 | $0.00 | 267,364.0000 | 324,754,000 | 15.50% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 132783 | $13.31 | 231,484.0000 | 324,754,000 | 36.45% | 0.04% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 305810 | $0.00 | 364,267.0000 | 324,754,000 | 523.14% | 0.09% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 10533 | $13.31 | 58,457.0000 | 324,754,000 | 15.27% | 0.00% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 24258 | $0.00 | 68,990.0000 | 324,754,000 | 54.23% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 16598 | $13.31 | 44,732.0000 | 324,754,000 | 27.06% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 38226 | $0.00 | 61,330.0000 | 324,754,000 | 165.45% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 10147 | $13.31 | 23,104.0000 | 324,754,000 | 30.52% | 0.00% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 22645 | $0.00 | 33,251.0000 | 324,754,000 | 213.51% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 35880 | $0.00 | 71,760.0000 | 324,754,000 | 33.33% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Performance-Based Restricted Stock Units | 305810 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.09% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 38226 | $0.00 | 38,227.0000 | 324,754,000 | 50.00% | 0.01% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | A | Restricted Stock Units | 65359 | $0.00 | 65,359.0000 | 324,754,000 | 9999.99% | 0.02% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | A | Performance-Based Restricted Stock Units | 65359 | $0.00 | 65,359.0000 | 324,754,000 | 9999.99% | 0.02% |
| Aug. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | S | Class A Common Stock | 22000 | $9.05 | 10,606.0000 | 308,978,000 | 67.47% | 0.01% |
| March 6, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | S | Class A Common Stock | 46936 | $8.73 | 32,606.0000 | 308,978,000 | 59.01% | 0.02% |
| March 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | S | Class A Common Stock | 43064 | $8.88 | 79,542.0000 | 308,978,000 | 35.12% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 38226 | $0.00 | 76,453.0000 | 308,978,000 | 33.33% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 22645 | $0.00 | 22,645.0000 | 308,978,000 | 9999.99% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 6943 | $8.76 | 15,702.0000 | 308,978,000 | 30.66% | 0.00% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 38226 | $0.00 | 53,928.0000 | 308,978,000 | 243.45% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 10864 | $8.76 | 43,064.0000 | 308,978,000 | 20.15% | 0.00% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 90580 | $0.00 | 133,644.0000 | 308,978,000 | 210.34% | 0.03% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 31338 | $8.76 | 102,306.0000 | 308,978,000 | 23.45% | 0.01% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Class A Common Stock | 35879 | $0.00 | 138,185.0000 | 308,978,000 | 35.07% | 0.01% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | F | Class A Common Stock | 15579 | $8.84 | 122,606.0000 | 308,978,000 | 11.27% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 22645 | $0.00 | 22,645.0000 | 308,978,000 | 50.00% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Performance-Based Restricted Stock Units | 90580 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.03% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | A | Performance-Based Restricted Stock Units | 194064 | $0.00 | 194,064.0000 | 308,978,000 | 9999.99% | 0.06% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | A | Restricted Stock Units | 97032 | $0.00 | 97,032.0000 | 308,978,000 | 9999.99% | 0.03% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | EVP, Chief Legal Officer | M | Restricted Stock Units | 35879 | $0.00 | 107,640.0000 | 308,978,000 | 25.00% | 0.01% |
| Nov. 21, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | S | Class A Common Stock | 13665 | $8.40 | 0.0000 | 309,647,000 | 100.00% | 0.00% |
| Nov. 15, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | S | Class A Common Stock | 43657 | $8.61 | 13,665.0000 | 309,647,000 | 76.16% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | M | Restricted Stock Units | 38226 | $0.00 | 114,679.0000 | 176,136,000 | 25.00% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | M | Restricted Stock Units | 22645 | $0.00 | 45,290.0000 | 176,136,000 | 33.33% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | F | Class A Common Stock | 10864 | $5.47 | 57,322.0000 | 176,136,000 | 15.93% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | M | Class A Common Stock | 38226 | $0.00 | 68,186.0000 | 176,136,000 | 127.59% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | F | Class A Common Stock | 7166 | $5.47 | 29,960.0000 | 176,136,000 | 19.30% | 0.00% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | M | Class A Common Stock | 22645 | $0.00 | 37,126.0000 | 176,136,000 | 156.38% | 0.01% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | A | Performance-Based Restricted Stock Units | 287038 | $0.00 | 287,038.0000 | 176,136,000 | 9999.99% | 0.16% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | A | Restricted Stock Units | 143519 | $0.00 | 143,519.0000 | 176,136,000 | 9999.99% | 0.08% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | F | Class A Common Stock | 8164 | $1.92 | 14,481.0000 | 150,944,000 | 36.05% | 0.01% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | M | Class A Common Stock | 22645 | $0.00 | 22,645.0000 | 150,944,000 | 9999.99% | 0.02% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | A | Restricted Stock Units | 152905 | $0.00 | 152,905.0000 | 150,944,000 | 9999.99% | 0.10% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | M | Restricted Stock Units | 22645 | $0.00 | 67,935.0000 | 150,944,000 | 25.00% | 0.02% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Daly Jason B. | SVP, Chief Legal Officer | A | Performance-Based Restricted Stock Units | 305810 | $0.00 | 305,810.0000 | 150,944,000 | 9999.99% | 0.20% |